Weight loss sector experienced some local abnormal fluctuations, Hebei Changshan Biochemical Pharmaceutical surged nearly 20% approaching the daily limit, followed by Brightgene Bio-medical Technology Co.,Ltd., Hybio Pharmaceutical, Jinkai Life Sciences, Xinjiang Bai Hua Cun Pharma Tech, and others. On the news front, the chairman and general manager of Hebei Changshan Biochemical Pharmaceutical, Gao Xiaodong, stated in an online exchange that the company has basically completed the on-site verification work of Aibonatin peptide conducted by the National Medical Products Administration Food and Drug Inspection Center and the registration inspection of Aibonatin peptide by China Food and Drug Inspection Institute. The conclusions of the on-site verification and registration inspection will be feedback to the drug evaluation center by the respective departments.